GLOBAVEND HOLDINGS LTD (GVH)

KYG3R39B1082 - Common Stock

0.73  -0.02 (-2.67%)

After market: 0.735 +0.01 (+0.68%)

Fundamental Rating

5

GVH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 21 industry peers in the Air Freight & Logistics industry. GVH has an excellent financial health rating, but there are some minor concerns on its profitability. GVH has a valuation in line with the averages, but it does not seem to be growing.



6

1. Profitability

1.1 Basic Checks

In the past year GVH was profitable.
GVH had a positive operating cash flow in the past year.

1.2 Ratios

GVH has a Return On Assets of 32.75%. This is amongst the best in the industry. GVH outperforms 100.00% of its industry peers.
GVH's Return On Equity of 45.27% is amongst the best of the industry. GVH outperforms 100.00% of its industry peers.
GVH's Return On Invested Capital of 44.46% is amongst the best of the industry. GVH outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GVH is significantly above the industry average of 10.93%.
The 3 year average ROIC (92.08%) for GVH is well above the current ROIC(44.46%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 32.75%
ROE 45.27%
ROIC 44.46%
ROA(3y)25.63%
ROA(5y)N/A
ROE(3y)113.48%
ROE(5y)N/A
ROIC(3y)92.08%
ROIC(5y)N/A

1.3 Margins

GVH has a better Profit Margin (7.33%) than 89.47% of its industry peers.
With an excellent Operating Margin value of 8.53%, GVH belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
GVH has a worse Gross Margin (13.21%) than 63.16% of its industry peers.
Industry RankSector Rank
OM 8.53%
PM (TTM) 7.33%
GM 13.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GVH is creating value.
GVH has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for GVH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

GVH has an Altman-Z score of 10.66. This indicates that GVH is financially healthy and has little risk of bankruptcy at the moment.
GVH has a Altman-Z score of 10.66. This is amongst the best in the industry. GVH outperforms 100.00% of its industry peers.
There is no outstanding debt for GVH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.66
ROIC/WACC4.84
WACC9.18%

2.3 Liquidity

GVH has a Current Ratio of 3.19. This indicates that GVH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of GVH (3.19) is better than 94.74% of its industry peers.
GVH has a Quick Ratio of 3.19. This indicates that GVH is financially healthy and has no problem in meeting its short term obligations.
GVH has a better Quick ratio (3.19) than 94.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.19

1

3. Growth

3.1 Past

GVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.36%, which is quite impressive.
GVH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.30%.
EPS 1Y (TTM)58.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.99%
Revenue 1Y (TTM)-19.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.21, the valuation of GVH can be described as very cheap.
Based on the Price/Earnings ratio, GVH is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
GVH is valuated cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.21
Fwd PE N/A

4.2 Price Multiples

GVH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GVH is cheaper than 94.74% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as GVH.
Industry RankSector Rank
P/FCF 85.81
EV/EBITDA 3.64

4.3 Compensation for Growth

GVH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GVH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GLOBAVEND HOLDINGS LTD

NASDAQ:GVH (1/15/2025, 1:59:15 PM)

After market: 0.735 +0.01 (+0.68%)

0.73

-0.02 (-2.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.14%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.67M
AnalystsN/A
Price TargetN/A
Short Float %1.66%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.21
Fwd PE N/A
P/S 0.4
P/FCF 85.81
P/OCF 17.63
P/B 2.45
P/tB 2.45
EV/EBITDA 3.64
EPS(TTM)0.14
EY19.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY1.17%
OCF(TTM)0.04
OCFY5.67%
SpS1.84
BVpS0.3
TBVpS0.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 32.75%
ROE 45.27%
ROCE 51.99%
ROIC 44.46%
ROICexc 104.91%
ROICexgc 104.91%
OM 8.53%
PM (TTM) 7.33%
GM 13.21%
FCFM 0.46%
ROA(3y)25.63%
ROA(5y)N/A
ROE(3y)113.48%
ROE(5y)N/A
ROIC(3y)92.08%
ROIC(5y)N/A
ROICexc(3y)1252.72%
ROICexc(5y)N/A
ROICexgc(3y)1252.72%
ROICexgc(5y)N/A
ROCE(3y)107.68%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover4.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 5045.85%
Cap/Sales 1.78%
Interest Coverage 250
Cash Conversion 26.2%
Profit Quality 6.29%
Current Ratio 3.19
Quick Ratio 3.19
Altman-Z 10.66
F-Score5
WACC9.18%
ROIC/WACC4.84
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.03%
Cap/Sales(5y)N/A
Profit Quality(3y)146.39%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y82.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y161.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.21%
OCF growth 3YN/A
OCF growth 5YN/A